Simplicity Wealth LLC Has $137,000 Position in Haleon plc (NYSE:HLN)

Simplicity Wealth LLC lowered its holdings in Haleon plc (NYSE:HLN) by 10.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 14,347 shares of the company’s stock after selling 1,630 shares during the quarter. Simplicity Wealth LLC’s holdings in Haleon were worth $137,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Sierra Ocean LLC bought a new stake in shares of Haleon during the fourth quarter worth $26,000. Versant Capital Management Inc raised its position in shares of Haleon by 2,029.1% during the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock worth $34,000 after acquiring an additional 3,348 shares during the last quarter. Toronto Dominion Bank raised its position in shares of Haleon by 3,470.0% during the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after acquiring an additional 3,470 shares during the last quarter. Geneos Wealth Management Inc. bought a new stake in shares of Haleon during the fourth quarter worth $35,000. Finally, Spire Wealth Management bought a new stake in shares of Haleon during the fourth quarter worth $39,000. Institutional investors own 6.67% of the company’s stock.

Wall Street Analyst Weigh In

HLN has been the subject of a number of recent research reports. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Haleon in a research report on Monday, March 3rd. Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Hsbc Global Res downgraded Haleon from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 5th. Finally, HSBC reiterated a “hold” rating on shares of Haleon in a report on Wednesday, March 5th. Six analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $10.95.

Haleon Trading Up 0.2 %

NYSE HLN opened at $10.40 on Wednesday. Haleon plc has a 12 month low of $7.89 and a 12 month high of $10.80. The stock has a 50-day simple moving average of $9.69 and a 200 day simple moving average of $9.87. The company has a market capitalization of $47.06 billion, a PE ratio of 30.57, a P/E/G ratio of 2.82 and a beta of 0.25. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44.

Haleon (NYSE:HLN) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The company had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.38 billion. Research analysts forecast that Haleon plc will post 0.43 EPS for the current year.

Haleon Increases Dividend

The firm also recently declared a — dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be issued a $0.1166 dividend. This is an increase from Haleon’s previous — dividend of $0.05. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, April 25th. Haleon’s dividend payout ratio is 58.97%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.